| | 163521-12-8 Basic information More.. |
| Product Name: | VILAZODONE | | Synonyms: | 2-BenzofurancarboxaMide,5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-;Vilazodonei;Vilazodone
5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide;5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide;Verazodone hydrochloride;VIIBRYD; 5-(4-[4-(5-CYANO-1H-INDOL-3-YL)BUTYL]PIPERAZIN-1-YL)BENZOFURAN-2-CARBOXAMIDE;CS-108;5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide | | CAS: | 163521-12-8 | | MF: | C26H27N5O2 | | MW: | 441.52 | | EINECS: | 1308068-626-2 | | Mol File: | 163521-12-8.mol |  |
Use
Vilazodone is a kind of serotonergic antidepressant developed by Merck KGaA Company. It is a novel compound with high affinity and selectivity for the 5-hydroxytrptamine (5-HT) transporter and 5-HT (1A) receptors. It is indicated for the treatment of major depressive disorder (MDD). It is can be used as an alternative drugs for other kind of antidepressant classes drugs that cant be tolerated by patients. As a selective serotonin reuptake inhibitor, vilazodone can prevent the serotonin from re-entering into cell bodies, therefore making it remain longer inside the synapse. Moreover, it has a high selectivity for the serotonin-1A receptor, taking effect as a partial agonist that can simulate the production of serotonin. These effects result in increased serotonin in the synaptic cleft. This effect is related to the antidepressant effect of vilazodone in vivo.
- Vilazodone
-
- US $54.00-197.00 / mg
- 2025-11-02
- CAS:163521-12-8
- Min. Order:
- Purity: 99.83%
- Supply Ability: 10g
- Vilazodone
-
- US $54.00-197.00 / mg
- 2025-11-02
- CAS:163521-12-8
- Min. Order:
- Purity: 99.83%
- Supply Ability: 10g
- VILAZODONE
-
- US $1.00 / kg
- 2025-10-29
- CAS:163521-12-8
- Min. Order: 0.1kg
- Purity: 99
- Supply Ability: 20
|
|
163521-12-8
Recommend Suppliers |
|